Emerging in the arena of obesity therapy, retatrutide is a unique strategy. Different from many existing medications, retatrutide functions as a twin agonist, at once targeting both glucagon-like peptide-1 (GLP-1) and https://umairjedf483750.theideasblog.com/39181928/this-new-retatrutide-this-glp-and-gip-binding-site-agonist